153 related articles for article (PubMed ID: 28619254)
1. 22q11.2 Deletion Syndrome: Characterization of Psychosis Spectrum and Future Directions.
Radoeva PD
Biol Psychiatry; 2017 Jul; 82(1):e5-e7. PubMed ID: 28619254
[No Abstract] [Full Text] [Related]
2. Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome.
Hooper SR; Shashi V
Schizophr Res; 2017 Oct; 188():33-34. PubMed ID: 28768602
[No Abstract] [Full Text] [Related]
3. Psychosis Beyond the 22q11.2 Deletion: Do Additional Genetic Factors Play a Role?
Goes FS; Sawa A
Am J Psychiatry; 2017 Nov; 174(11):1027-1029. PubMed ID: 29088933
[No Abstract] [Full Text] [Related]
4. [Diagnosis of 22q11.2 deletion syndrome in the context of newly developed psychosis].
Kaltenboeck A; Friedrich F; Hinterbuchinger B; Litvan Z; Mossaheb N
Neuropsychiatr; 2016 Dec; 30(4):223-226. PubMed ID: 27822729
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
[TBL] [Abstract][Full Text] [Related]
6. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
Stoddard J; Niendam T; Hendren R; Carter C; Simon TJ
Schizophr Res; 2010 May; 118(1-3):118-21. PubMed ID: 20056393
[TBL] [Abstract][Full Text] [Related]
7. Metyrosine in psychosis associated with 22q11.2 deletion syndrome: case report.
Carandang CG; Scholten MC
J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):115-20. PubMed ID: 17343559
[TBL] [Abstract][Full Text] [Related]
8. Basal ganglia calcification and psychosis in 22q11.2 deletion syndrome.
Sieberer M; Haltenhof H; Haubitz B; Pabst B; Miller K; Garlipp P
Eur Psychiatry; 2005 Dec; 20(8):567-9. PubMed ID: 15967641
[TBL] [Abstract][Full Text] [Related]
9. Exploring the potential association among sleep disturbances, cognitive impairments, and immune activation in 22q11.2 deletion syndrome.
Yirmiya ET; Mekori-Domachevsky E; Weinberger R; Taler M; Carmel M; Gothelf D
Am J Med Genet A; 2020 Mar; 182(3):461-468. PubMed ID: 31837200
[TBL] [Abstract][Full Text] [Related]
10. Subcortical Signatures of Hemizygosity and Psychosis in 22q11.2 Deletion Syndrome: Finding Common Ground in Rare Genetic Variation.
Eisenberg DP; Gregory MD; Berman KF
Am J Psychiatry; 2020 Jul; 177(7):564-566. PubMed ID: 32605438
[No Abstract] [Full Text] [Related]
11. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
[TBL] [Abstract][Full Text] [Related]
12. Movement Disorder Phenotypes in Children With 22q11.2 Deletion Syndrome.
Cunningham AC; Fung W; Massey TH; Hall J; Owen MJ; van den Bree MBM; Peall KJ
Mov Disord; 2020 Jul; 35(7):1272-1274. PubMed ID: 32379361
[No Abstract] [Full Text] [Related]
13. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
Prasad SE; Howley S; Murphy KC
Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
[TBL] [Abstract][Full Text] [Related]
14. Views of adults with 22q11 deletion syndrome on reproductive choices.
McNeill A; Lewis R; Freeth M
Am J Med Genet A; 2020 May; 182(5):1284-1287. PubMed ID: 32154643
[No Abstract] [Full Text] [Related]
15. Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson's disease?
Fung W; Peall KJ
J Neurol; 2018 Oct; 265(10):2463-2465. PubMed ID: 30238269
[No Abstract] [Full Text] [Related]
16. Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome).
Jolin EM; Weller RA; Weller EB
Curr Psychiatry Rep; 2009 Apr; 11(2):99-105. PubMed ID: 19302762
[TBL] [Abstract][Full Text] [Related]
17. No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patients.
Guipponi M; Santoni F; Schneider M; Gehrig C; Bustillo XB; Kates WR; Morrow B; Armando M; Vicari S; Sloan-Béna F; Gagnebin M; Shashi V; Hooper SR; Eliez S; Antonarakis SE
Transl Psychiatry; 2017 Feb; 7(2):e1039. PubMed ID: 28221368
[TBL] [Abstract][Full Text] [Related]
18. Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome.
Lawrence S; McDonald-McGinn DM; Zackai E; Sullivan KE
J Pediatr; 2003 Aug; 143(2):277-8. PubMed ID: 12970648
[TBL] [Abstract][Full Text] [Related]
19. The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome.
Van Esch H; Groenen P; Fryns JP; Van de Ven W; Devriendt K
Genet Couns; 1999; 10(1):59-65. PubMed ID: 10191430
[TBL] [Abstract][Full Text] [Related]
20. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome.
Gothelf D; Schaer M; Eliez S
Dev Disabil Res Rev; 2008; 14(1):59-68. PubMed ID: 18636637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]